Is there a future for AKT inhibitors in the treatment of cancer?

Valerie M. Jansen, Ingrid A. Mayer, Carlos L. Arteaga

Research output: Contribution to journalArticle

18 Scopus citations

Abstract

An AKT inhibitor plus an antiestrogen exhibited no significant clinical activity in patients with ER+/HER2- breast cancer despite laboratory studies supporting an antitumor effect for both drugs combined. These results raise concerns about the development of AKT inhibitors in unselected patients whose tumors have unknown dependence on the PI3K/AKT pathway.

Original languageEnglish (US)
Pages (from-to)2599-2601
Number of pages3
JournalClinical Cancer Research
Volume22
Issue number11
DOIs
StatePublished - Jun 1 2016

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Is there a future for AKT inhibitors in the treatment of cancer?'. Together they form a unique fingerprint.

  • Cite this